Sutherland EW - Search Results

1

Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisis.

Overton J, Denton K, Frumovitz M, Lewis C, Christensen S, Bezerra J, Hernandez C, Walker MS, Finder JP, Proske AA, Jain S, Whipple J, Martinez WL, Eska JS, Sutherland EW, Triche LL, Garcia EA, Weber RS. Overton J, et al. Among authors: sutherland ew. Head Neck. 2020 Jul;42(7):1477-1481. doi: 10.1002/hed.26259. Epub 2020 May 16. Head Neck. 2020. PMID: 32415893 Free PMC article.

2

Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Golightly LK, Smolinske SS, Bennett ML, Sutherland EW 3rd, Rumack BH. Golightly LK, et al. Among authors: sutherland ew 3rd. Med Toxicol Adverse Drug Exp. 1988 May-Jun;3(3):209-40. doi: 10.1007/BF03259883. Med Toxicol Adverse Drug Exp. 1988. PMID: 3041246 Review. No abstract available.

3

Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).

Golightly LK, Smolinske SS, Bennett ML, Sutherland EW 3rd, Rumack BH. Golightly LK, et al. Among authors: sutherland ew 3rd. Med Toxicol Adverse Drug Exp. 1988 Mar-Apr;3(2):128-65. Med Toxicol Adverse Drug Exp. 1988. PMID: 3287089 Review.

4

Documenting the activity and effectiveness of a regional drug information center.

Golightly LK, Davis AG, Budwitz WJ, Gelman CJ, Rathmann KL, Sutherland EW, Rumack BH. Golightly LK, et al. Among authors: sutherland ew. Am J Hosp Pharm. 1988 Feb;45(2):356-61. Am J Hosp Pharm. 1988. PMID: 3364436

5

Long-term follow-up of a patient with quadruple valve replacement.

Hossack KF, Hopeman AR, Sutherland EW 3rd. Hossack KF, et al. Among authors: sutherland ew 3rd. Tex Heart Inst J. 1987 Sep;14(3):315-7. Tex Heart Inst J. 1987. PMID: 15227319 Free PMC article.

6

Exercise and beta-blocking agents.

Golightly LK, Sutherland EW 3rd. Golightly LK, et al. Among authors: sutherland ew 3rd. Drug Intell Clin Pharm. 1985 Apr;19(4):302-4. doi: 10.1177/106002808501900414. Drug Intell Clin Pharm. 1985. PMID: 2861073

7

Medication problems handled by a consumer-oriented drug information center.

Conner CS, Sawyer DR, Sbarbaro JA, Sutherland EW, Gelman CJ, Smolinske SC, Rathmann KL. Conner CS, et al. Among authors: sutherland ew. Am J Hosp Pharm. 1982 May;39(5):849-51. Am J Hosp Pharm. 1982. PMID: 7081264 No abstract available.

8

Phenytoin toxicity and blood levels after a large oral dose.

Evens RP, Fraser DG, Ludden TM, Sutherland EW 3rd. Evens RP, et al. Among authors: sutherland ew 3rd. Am J Hosp Pharm. 1980 Feb;37(2):232-5. Am J Hosp Pharm. 1980. PMID: 7361796

9

Displacement of phenytoin from plasma binding sites by salicylate.

Fraser DG, Ludden TM, Evens RP, Sutherland EW 3rd. Fraser DG, et al. Among authors: sutherland ew 3rd. Clin Pharmacol Ther. 1980 Feb;27(2):165-9. doi: 10.1038/clpt.1980.25. Clin Pharmacol Ther. 1980. PMID: 7353334 Clinical Trial.

10

Adenosine 3':5'-monophosphate content and actions in the division cycle of synchronized HeLa cells.

Zeilig CE, Johnson RA, Sutherland EW, Friedman DL. Zeilig CE, et al. Among authors: sutherland ew. J Cell Biol. 1976 Nov;71(2):515-34. doi: 10.1083/jcb.71.2.515. J Cell Biol. 1976. PMID: 186461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters